PCM
ENZY

Penserra Capital Management’s Enzymotec Ltd ENZY Stock Holding History

Penserra Capital Management’s Portfolio ENZY Stock Details ENZY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-5,558
Closed -$48K – 611
2017
Q1 		$48K Buy
5,558
+2,382
+75% +$20.2K 0.01% 334
2016
Q4 		$20K Sell
3,176
-324
-9% -$2.13K ﹤0.01% 644
2016
Q3 		$24K Buy
3,500
+875
+33% +$7.01K ﹤0.01% 466
2016
Q2 		$22K Buy
2,625
+564
+27% +$4.67K ﹤0.01% 466
2016
Q1 		$18 Buy
2,061
+687
+50% +$5.99K ﹤0.01% 463
2015
Q4 		$13K Buy
+1,374
New +$13K ﹤0.01% 484

Other funds holding ENZY

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
TM
Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Ohio Public Employees Retirement System (OPERS)
Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $30.9B AUM 29.72% 1-Year Est. Return

Penserra Capital Management's ENZY Position: Q2 2017 in Review

Penserra Capital Management sold out of Enzymotec Ltd (ENZY) in Q2 2017, closing a stake of 5,558 shares — an estimated $48K sold.

Penserra Capital Management first reported a position in ENZY in Q4 2015 and held it in 6 quarters. The position peaked at $48K in Q1 2017. 21 funds tracked by Wall St. Rank hold ENZY as of Q2 2017.

  • Penserra Capital Management reported no remaining Enzymotec Ltd position as of Q2 2017 after selling out during the quarter.
  • Penserra Capital Management sold 5,558 Enzymotec Ltd shares in Q2 2017, an estimated $48K.
  • Penserra Capital Management first reported a position in Enzymotec Ltd in Q4 2015 and held it in 6 quarters.
  • Penserra Capital Management's Enzymotec Ltd position peaked at $48K in Q1 2017.
  • 21 funds tracked by Wall St. Rank held Enzymotec Ltd as of Q2 2017.

Based on Penserra Capital Management's 13F filing for Q2 2017, filed 7 Aug 2017.